(Q38395713)

English

Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children

scientific article published on 08 July 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

Shabir A. Madhi

4

object named as

S A Madhi

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Z Ditse

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

P V Adrian

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

L Kuwanda

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

8 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

4421-4427

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Impact of the pneumococcal conjugate vaccine on otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Serotype replacement in disease after pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Pneumococcal vaccines: an update on current strategies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Competence and virulence of Streptococcus pneumoniae: Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Development of lactococcal GEM-based pneumococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Development of natural antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A and pneumolysin in Filipino pregnant women and their infants in relation to pneumococcal carriage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Nasopharyngeal colonization elicits antibody responses to staphylococcal and pneumococcal proteins that are not associated with a reduced risk of subsequent carriage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

The streptococcal lipoprotein rotamase A (SlrA) is a functional peptidyl-prolyl isomerase involved in pneumococcal colonization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Antibody-enhanced pneumococcal adherence requires IgA1 protease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Human antibodies to pneumococcal surface protein A in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae--and associated interactions with Staphylococcus aureus and Haemophilus influenzae colonization--in HIV-Infected and HIV-uninfected childre

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Zero-length crosslinking procedure with the use of active esters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

A Multiplexed Fluorescent Microsphere Immunoassay for Antibodies to Pneumococcal Capsular Polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Impaired natural immunity to pneumolysin during human immunodeficiency virus infection in the United States and Africa.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Effect of recurrent invasive pneumococcal disease on serum anti-pneumolysin IgG titres in HIV infected adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Antipneumolysin antibody titers in HIV-seropositive injection drug users before and after pneumococcal bacteremia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

6th International Symposium on Pneumococci and Pneumococcal Diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

The prevalence and risk factors for pneumococcal colonization of the nasopharynx among children in Kilifi District, Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Impact of human immunodeficiency virus infection on Streptococcus pneumoniae colonization and seroepidemiology among Zambian women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

A novel solenoid fold in the cell wall anchoring domain of the pneumococcal virulence factor LytA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Impaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonization rates, seroepidemiology and antibiotic resistance in Zambian infants: a longitudinal cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

based on heuristic

inferred from DOI database lookup

Cloning and nucleotide sequence analysis of psaA, the Streptococcus pneumoniae gene encoding a 37-kilodalton protein homologous to previously reported Streptococcus sp. adhesins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.06.097

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2013.06.097

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38395713&oldid=2183493928"